Income StatementBalance SheetCash FlowSegments
Insmed logo

Insmed Cash Flow Statement

Operating, investing, and financing cash movements

Insmed generated -$895.7M in operating cash flow over the trailing twelve months. After $26.0M in capital expenditures, free cash flow was -$921.6M. Free cash flow decreased 0.2% year-over-year. Based on the Q1 2026 filing.

Net Cash From Operating (TTM)-$895.7MNet Cash From Investing (TTM)-$714.9MNet Cash From Financing (TTM)$954.6MCapital Expenditures (TTM)$26.0MDepreciation And Amortization Cf (TTM)$11.5MNet Change In Cash (TTM)-$126.7M
Latest FilingQ1 2026
Report Date2026-05-07
Market Cap$23.2B
ROE-294.46%

Operating

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Amortization of debt issuance costs$1.7M$1.8M$1.7M$1.3M$1.4M$1.4M
Amortization of intangible assets$1.3M$1.3M$1.3M$1.5M$1.9M$2.1M
Change in accounts payable$41.1M-$61.5M$25.7M$45.6M$90.3M-$33.9M
Change in accounts receivable$11.8M-$5.4M$6.1M$10.2M$77.3M$38.2M
Change in inventories$2.1M$1.0M$5.0M$13.8M$11.8M$1.9M
Change in other assets-$2.7M-$10.2M-$2.3M$2.9M$11.8M$2.4M
Change in other liabilities-$4.6M-$2.2M-$815.0K-$1.1M-$914.0K-$497.0K
Other working capital changes$5.1M$5.0M$5.2M$5.1M$5.3M$5.1M
Change in fair value of contingent consideration—$18.3M$59.0M$104.7M$70.0M-$47.0M
Depreciation and amortization$1.5M$1.9M$2.5M$2.5M$3.6M$2.9M
Net cash from operating activities-$196.0M-$262.1M-$205.6M-$219.8M-$247.6M-$222.7M
Net income-$235.5M-$256.6M-$321.7M-$370.0M-$328.5M-$163.6M
Non-cash operating lease expense$1.4M$686.0K$888.0K$1.2M$6.9M$567.0K
Stock-based compensation$26.6M$39.3M$43.0M$31.4M$39.0M$45.8M

Investing

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Capital expenditures$6.8M$10.1M$3.5M$2.4M$16.6M$3.5M
Payment Of Milestone$0.0$0.0———$15.0M
Net cash from investing activities—$80.4M$227.8M-$762.2M—$265.5M
Proceeds from maturities/sales of investments$716.0M$721.0M$508.0M$425.0M$436.0M$284.0M

Free Cash Flow

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Free cash flow-$202.8M-$272.2M-$209.1M-$222.2M-$264.2M-$226.2M

Other

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Effect of exchange rate changes on cash-$1.5M$895.0K$1.0M-$976.0K$7.0K-$553.0K
Net increase (decrease) in cash$93.6M-$151.8M$881.1M-$949.6M—$71.7M
Finance Lease Right Of Use Asset Amortization$678.0K$678.0K$678.0K$678.0K$678.0K$678.0K

Supplemental

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Income taxes paid$248.0K$2.2M$677.0K$1.2M$111.0K$2.9M
Interest paid$15.2M$13.1M$13.3M$15.5M$13.5M$13.1M

Financing

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Net cash from financing activities$159.3M$29.0M$857.8M$33.4M$33.9M$29.5M
Payments for finance leases$686.0K$706.0K$732.0K$747.0K$776.0K$799.0K
Proceeds from issuance of common stock$0.0$29.7M$793.8M-$256.0K$0.0$30.3M